Charlie Sheen and CytoDyn CEO appear together on popular TV show; Sheen very excited to explore possibility of participating in PRO 140 monotherapy trial Feb 11, 2016
Almost zero HIV transmission rates possible, return to normal life FDA trial expects to document 5-fold drop in viral loads within one week of one dose of PRO 140 Sep 10, 2015 Subscribe to Jerry Jennings